glp-1 receptor Frontiers Prolonged Activation of the GLP-1
Description
GLP-1 receptor agonists fall far outside that category
This makes them much better suited to treatment compliance than addiction therapies which require daily administration (and it should be noted that several longer acting formulations of existing SUD medications are coming to market as well)
Not a problem anymore
Are they legitimate or another gimmick
